GL1X · GenesisL1 explorer

MolNFT v1 · #155400 · protein

Human PDE5 catalytic core in complex with avanafil

6L6E · Cgmp-specific 3',5'-cyclic phosphodiesterase: “Human PDE5 catalytic core in complex with avanafil”. X-ray diffraction, 4 ligands (E6L, ZN, MG), 3 pockets (best druggability 0.74). MolNFT v1 #155400 on GenesisL1: 3D structure…

PDB
6L6E
Type
protein
Length
324 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Cgmp-specific 3',5'-cyclic phosphodiesterase
EC
3.1.4.35
UniProt
O76074
Ligands
E6L, ZN, MG, SO4
Pockets
3 · best druggability 0.74

Structure

x-ray diffraction · 1 distinct chain · 72% helix, 0% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ACgmp-specific 3',5'-cyclic phosphodiesterase (EC 3.1.4.35)protein32472% helix, 0% strandO76074

Ligands and binding sites

  • E6L · 4-[(3-chloranyl-4-methoxy-phenyl)methylamino]-2-[(2S)-2-(hydroxymethyl)pyrrolidin-1-yl]-N-(pyrimidin-2-ylmethyl)pyrimid ine-5-carboxamide · ligand · chains A
  • ZN · Zinc ion · metal · chains A
  • MG · Magnesium ion · metal · chains A
  • SO4 · Sulfate ion · ion · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

3 pockets found on a 1 Å grid, 2 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
14160.740.8437E6L, MG, SO4
2600.570.9019empty
3850.470.8221empty

Compared structures

  • 6L6E · Human PDE5 catalytic core in complex with avanafil · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.